Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $15,700 | 7 | 69.9% |
| Food and Beverage | $3,276 | 55 | 14.6% |
| Travel and Lodging | $1,905 | 6 | 8.5% |
| Honoraria | $1,575 | 1 | 7.0% |
| Education | $7.90 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $17,092 | 18 | $0 (2022) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $2,520 | 9 | $0 (2022) |
| Ironwood Pharmaceuticals, Inc | $1,364 | 2 | $0 (2017) |
| Novartis Pharmaceuticals Corporation | $319.46 | 24 | $0 (2024) |
| Abbott Laboratories | $317.24 | 4 | $0 (2023) |
| ABIOMED | $155.07 | 2 | $0 (2022) |
| Medtronic Vascular, Inc. | $153.29 | 4 | $0 (2018) |
| United Therapeutics Corporation | $141.80 | 2 | $0 (2024) |
| Akcea Therapeutics, Inc. | $124.99 | 1 | $0 (2019) |
| Esperion Therapeutics, Inc. | $120.02 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $326.29 | 19 | Novartis Pharmaceuticals Corporation ($184.44) |
| 2023 | $18.54 | 1 | Abbott Laboratories ($18.54) |
| 2022 | $4,950 | 8 | PFIZER INC. ($2,531) |
| 2021 | $3,008 | 8 | PFIZER INC. ($2,536) |
| 2020 | $9,360 | 13 | PFIZER INC. ($9,292) |
| 2019 | $2,858 | 4 | PFIZER INC. ($2,733) |
| 2018 | $275.27 | 6 | Abbott Laboratories ($130.01) |
| 2017 | $1,667 | 11 | Ironwood Pharmaceuticals, Inc ($1,364) |
All Payment Transactions
70 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $2.26 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/04/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $3.37 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/07/2024 | United Therapeutics Corporation | — | Food and Beverage | In-kind items and services | $124.99 | General |
| 10/23/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $2.36 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/01/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $3.93 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/25/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $7.63 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/04/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $24.39 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/23/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $3.65 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/25/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $7.71 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/12/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $2.51 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/01/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $3.83 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/12/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $1.56 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/06/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $22.85 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/07/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $5.25 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/16/2024 | Alnylam Pharmaceuticals Inc. | ONPATTRO (Drug) | Food and Beverage | In-kind items and services | $16.86 | General |
| Category: Genetic Disease | ||||||
| 04/04/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $32.25 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/14/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $8.96 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/01/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $32.13 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 01/25/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/13/2023 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: Heart Failure | ||||||
| 12/19/2022 | PFIZER INC. | VYNDAQEL (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $6.19 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/17/2022 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $19.29 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/19/2022 | United Therapeutics Corporation | TYVASO (Drug), ORENITRAM | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: PAH | ||||||
| 06/08/2022 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $750.00 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 05/26/2022 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $65.24 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,075 | 1,469 | $254,875 | $95,955 |
| 2022 | 19 | 1,307 | 1,767 | $260,637 | $98,887 |
| 2021 | 18 | 1,356 | 1,745 | $289,540 | $118,746 |
| 2020 | 17 | 1,131 | 1,522 | $274,139 | $103,299 |
All Medicare Procedures & Services
73 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 291 | 484 | $114,681 | $42,303 | 36.9% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 27 | 76 | $33,744 | $12,472 | 37.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 40 | 40 | $16,240 | $6,567 | 40.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 40 | 48 | $15,936 | $6,412 | 40.2% |
| 93290 | Evaluation of implantable heart and blood vessel monitoring system | Office | 2023 | 136 | 166 | $9,960 | $5,646 | 56.7% |
| 93297 | Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | Office | 2023 | 219 | 280 | $15,120 | $5,262 | 34.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 34 | 34 | $9,316 | $3,397 | 36.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 21 | 21 | $8,442 | $2,797 | 33.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 31 | 44 | $5,882 | $2,673 | 45.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 19 | 19 | $6,156 | $2,411 | 39.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 20 | 26 | $5,356 | $2,376 | 44.4% |
| 93264 | Remote monitoring of pulmonary artery pressure sensor, up to 30 days | Office | 2023 | 21 | 44 | $5,192 | $1,612 | 31.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 23 | 23 | $4,416 | $1,100 | 24.9% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 101 | 112 | $2,016 | $517.92 | 25.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 25 | 25 | $1,050 | $195.92 | 18.7% |
| 93227 | Electrocardiogram (ecg) 2-day continuous with review by health care professional | Facility | 2023 | 14 | 14 | $1,134 | $168.84 | 14.9% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2023 | 13 | 13 | $234.00 | $43.68 | 18.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 277 | 508 | $120,288 | $44,901 | 37.3% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 32 | 62 | $27,528 | $10,506 | 38.2% |
| 93290 | Evaluation of implantable heart and blood vessel monitoring system | Office | 2022 | 156 | 213 | $12,780 | $7,560 | 59.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 42 | 49 | $16,268 | $5,840 | 35.9% |
| 93297 | Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | Office | 2022 | 206 | 237 | $12,798 | $4,479 | 35.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 47 | 73 | $10,305 | $3,935 | 38.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 22 | 23 | $9,246 | $3,525 | 38.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 19 | 19 | $7,714 | $2,920 | 37.9% |
About Dr. Amit Varma, MD
Dr. Amit Varma, MD is a Internal Medicine healthcare provider based in Lancaster, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/22/2007. The National Provider Identifier (NPI) number assigned to this provider is 1477762425.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Amit Varma, MD has received a total of $22,464 in payments from pharmaceutical and medical device companies, with $326.29 received in 2024. These payments were reported across 70 transactions from 13 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($15,700).
As a Medicare-enrolled provider, Varma has provided services to 4,869 Medicare beneficiaries, totaling 6,503 services with total Medicare billing of $416,887. Data is available for 4 years (2020–2023), covering 73 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Cardiovascular Disease, Advanced Heart Failure and Transplant Cardiology
- Location Lancaster, PA
- Active Since 05/22/2007
- Last Updated 05/08/2017
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1477762425
Products in Payments
- VYNDAQEL (Drug) $13,616
- LifeVest (Device) $2,520
- IW-1973 $1,364
- ENTRESTO (Drug) $246.79
- Circulatory Support (Device) $168.69
- Impella (Device) $155.07
- HeartWare HVAD (Device) $126.90
- TEGSEDI (Drug) $124.99
- NEXLETOL (Drug) $120.02
- Barostim Neo System (Device) $119.41
- Quadra Allure MP RF CRT Pacemkr (Device) $109.44
- LEQVIO (Drug) $72.67
- CardioMEMS HF System (Device) $20.57
- CARDIOMEMS (Device) $18.54
- ONPATTRO (Drug) $16.86
- TYVASO (Drug) $16.81
- Advisa (Device) $15.26
- Micra (Device) $11.13
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Lancaster
Dr. Justin Roberts, D.o, D.O
Internal Medicine — Payments: $108,112
Tareck Nossuli, M.d, M.D
Internal Medicine — Payments: $66,290
Doreen Bett, D.o, D.O
Internal Medicine — Payments: $52,933
Dr. Michelle Jordan, Do, DO
Internal Medicine — Payments: $47,704
Dr. Sami Nafoosi, Md, MD
Internal Medicine — Payments: $35,747
Dr. Davy Figueroa, M.d, M.D
Internal Medicine — Payments: $27,435